Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer

Descripción del Articulo

Purpose: Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with th...

Descripción completa

Detalles Bibliográficos
Autores: Castaneda, Carlos, Castillo, Miluska, Chavez, I, Barreda, F, Suarez, N, Nieves, J, Bernabe, LA, Valdivia, D, Ruiz, E, Dias-Neto, E, Landa-Baella, MP, Bazan, Y, Rengifo, CA, Montenegro, P
Formato: artículo
Fecha de Publicación:2019
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:inen/63
Enlace del recurso:https://repositorio.inen.sld.pe/handle/inen/63
Nivel de acceso:acceso abierto
Materia:Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_932cc3975d158193a6e212165864e7b8
oai_identifier_str oai:repositorio.inen.sld.pe:inen/63
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling Castaneda, CarlosCastillo, MiluskaChavez, IBarreda, FSuarez, NNieves, JBernabe, LAValdivia, DRuiz, EDias-Neto, ELanda-Baella, MPBazan, YRengifo, CAMontenegro, P2024-04-05T15:45:35Z2024-04-05T15:45:35Z2019Purpose: Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. Patients and methods: A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. Results: Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P < .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P < .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. Conclusion: Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC.application/pdf10.1200/JGO.19.00122https://repositorio.inen.sld.pe/handle/inen/63engJCO Global OncologyUSAmerican Society of Clinical Oncologyinfo:eu-repo/semantics/openAccessdc.rights.uri: https//creativecomons.org/licenses/by/4.0/DspaceOpen accessRepositorio digitalhttps://purl.org/pe-repo/ocde/ford#3.02.21Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancerinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENPublicationORIGINALCarlos A. Castaneda, 2019, JGO.pdfapplication/pdf695382https://repositorio.inen.sld.pe/bitstreams/700a1930-783a-4378-b590-5b231f26272e/download0393f500e9dd8b2fc0ee17479f0a1f19MD51TEXTCarlos A. Castaneda, 2019, JGO.pdf.txtCarlos A. Castaneda, 2019, JGO.pdf.txtExtracted texttext/plain40543https://repositorio.inen.sld.pe/bitstreams/3f7eaf2f-a0db-4029-bd50-890af8bb6f7e/download0900aa7f37a53b830f86e9d6b82d2679MD52THUMBNAILCarlos A. Castaneda, 2019, JGO.pdf.jpgCarlos A. Castaneda, 2019, JGO.pdf.jpgGenerated Thumbnailimage/jpeg5722https://repositorio.inen.sld.pe/bitstreams/e739ace5-bca1-4f11-990b-ba0097cccbee/download5d53e799511fb7daa15c33b4ba29559aMD53inen/63oai:repositorio.inen.sld.pe:inen/632024-10-23 18:08:26.44dc.rights.uri: https//creativecomons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttps://repositorio.inen.sld.peRepositorio INENrepositorioinendspace@gmail.com
dc.title.none.fl_str_mv Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
title Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
spellingShingle Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
Castaneda, Carlos
Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
title_full Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
title_fullStr Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
title_full_unstemmed Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
title_sort Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer
author Castaneda, Carlos
author_facet Castaneda, Carlos
Castillo, Miluska
Chavez, I
Barreda, F
Suarez, N
Nieves, J
Bernabe, LA
Valdivia, D
Ruiz, E
Dias-Neto, E
Landa-Baella, MP
Bazan, Y
Rengifo, CA
Montenegro, P
author_role author
author2 Castillo, Miluska
Chavez, I
Barreda, F
Suarez, N
Nieves, J
Bernabe, LA
Valdivia, D
Ruiz, E
Dias-Neto, E
Landa-Baella, MP
Bazan, Y
Rengifo, CA
Montenegro, P
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castaneda, Carlos
Castillo, Miluska
Chavez, I
Barreda, F
Suarez, N
Nieves, J
Bernabe, LA
Valdivia, D
Ruiz, E
Dias-Neto, E
Landa-Baella, MP
Bazan, Y
Rengifo, CA
Montenegro, P
dc.subject.none.fl_str_mv Dspace
Open access
Repositorio digital
topic Dspace
Open access
Repositorio digital
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Purpose: Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. Patients and methods: A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. Results: Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P < .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P < .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. Conclusion: Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC.
publishDate 2019
dc.date.accessioned.none.fl_str_mv 2024-04-05T15:45:35Z
dc.date.available.none.fl_str_mv 2024-04-05T15:45:35Z
dc.date.issued.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1200/JGO.19.00122
dc.identifier.uri.none.fl_str_mv https://repositorio.inen.sld.pe/handle/inen/63
identifier_str_mv 10.1200/JGO.19.00122
url https://repositorio.inen.sld.pe/handle/inen/63
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv American Society of Clinical Oncology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv JCO Global Oncology
dc.publisher.country.none.fl_str_mv US
publisher.none.fl_str_mv JCO Global Oncology
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/bitstreams/700a1930-783a-4378-b590-5b231f26272e/download
https://repositorio.inen.sld.pe/bitstreams/3f7eaf2f-a0db-4029-bd50-890af8bb6f7e/download
https://repositorio.inen.sld.pe/bitstreams/e739ace5-bca1-4f11-990b-ba0097cccbee/download
bitstream.checksum.fl_str_mv 0393f500e9dd8b2fc0ee17479f0a1f19
0900aa7f37a53b830f86e9d6b82d2679
5d53e799511fb7daa15c33b4ba29559a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio INEN
repository.mail.fl_str_mv repositorioinendspace@gmail.com
_version_ 1845608107382669312
score 12.786421
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).